Immunological studies before and during interferon therapy in chronic HBV infection: Identification of factors predicting response
Linda J. Scully, David Brown, Chris Lloyd, Ruvan Shein, Howard C. Thomas – 1 November 1990 – Lymphoblastoid interferon is effective therapy in some but not all patients with chronic hepatitis B virus infection. To assess whether immunological parameters were predictive of response to interferon therapy, we determined the human leukocyte antigen type, CD4/CD8 ratio, natural killer cell activity, IgM anti‐HBc antibody levels and concanavalin A—induced lymphocyte proliferative response in 30 patients before treatment.